monga
VIP Member
Maybe ? you'd think they'd approve it already saying as it's not as hard work as Pfizer.Other countries alongside UK such as India, Mexico and Argentina have approved the use of the Oxford AstraZeneca in all ages groups.
The Oxford-AZ developers say that results from a trial of 2,000 adults over 55 in the UK will soon be available, and another trial in the US in older age groups is close to providing data too.
Perhaps when the data of the above trials become available and are promising - EU countries may approve for the use in over 65’s.